MoneyWorks4Me

Bharat Immunologicals & Biologicals Corporation informs about limited review report

12 Nov 2018 Evaluate

In pursuance of Regulation 33(3) (C) of the LODR, Bharat Immunologicals & Biologicals Corporation has informed about the submission of Limited Review Report along with the financial results for the Quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..